ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0724

Synovial Macrophage Subsets Defined by ScRNAseq Demonstrate Sexually Dimorphic Gene Expression in RA and a Mouse Inflammatory Arthritis Model

Richard Bell, Ewurama Cann, Chao Yang, Accelerating Medicine Partnership Rheumatoid Arthritis, Amit Lakhanpal, Laura Donlin and Lionel Ivashkiv, Hospital for Special Surgery, New York, NY

Meeting: ACR Convergence 2023

Keywords: Innate Immunity Rheumatic Disease, interferon, macrophages, rheumatoid arthritis, sex hormones

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: Plenary I

Session Type: Plenary Session

Session Time: 11:00AM-12:30PM

Background/Purpose: Macrophages (MФ) play a key pathogenic role in Rheumatoid Arthritis (RA), a disease that exhibits female sex bias. Recent work using scRNAseq has defined putative pathogenic synovial MФ subtypes in RA. It is not known whether these MФ subtypes exhibit sexually dimorphic gene expression that can contribute to female sex bias. Additionally, the causal role of RA MФ subsets in inflammatory arthritis is difficult to ascertain in the absence of a disease model that recapitulates these cells’ phenotype and gene expression. We tested the hypothesis that pathogenic MФ subsets express higher levels of inflammatory genes in females, and developed a mouse model that recapitulates select RA MФ subsets and the sexually dimorphic gene expression pattern.

Methods: We analyzed the myeloid scRNAseq data from the Accelerating Medicines Partnership-RA (AMP-RA) consortium1 comprised of ~76K cells from human synovial biopsies with RA clustered into 5 MФ subsets (MERTK+, SPP1+, C1QA+, CXCL10+/STAT1+ and IL1β+/PLCG2+). We performed differential gene expression (DEG) and GSEA between female (n=55) and male (n=20) RA subjects. Zymosan induced arthritis (ZIA) was induced via intra-articular injection of 180 ug of zymosan in female and male, WT and Tg8 (transgenic for human TLR8) mice.scRNAseq of synovial tissue CD45+ cells depleted of neutrophils at peak ZIA disease, D7 and DEG with GSEA between female and male mice was performed. We also performed qPCR analysis of FACS-sorted immune cells at D2 of disease and histologic analysis at D28. To assess the similarity between human RA and ZIA, we performed scRNAseq mouse-to-human (M2H) transfer learning to map mouse cells to human defined clusters. Appropriate t-test and two-ANOVA’s with Tukey’s post-hoc tests were used for all statistical analysis.

Results: GSEA demonstrated that the MERTK+, SPP1+ and CXCL10+/STAT1+ RA myeloid synovial cell clusters showed significant female bias in IFN and other inflammatory pathways (Fig 1A-C, FDR < 0.05, LFC >1). The M2H model produced high quality predictions with an overall F1 score of 0.76 ± 0.1 and revealed that ~60% of cells in the mouse ZIA synovium map to human RA synovial myeloid cell subsets (Fig 1D) validating our approach. After sub-setting the myeloid cells in ZIA synovium (Fig 2A) and re-clustering (Fig 2B), 4 of 7 clusters (C1, C3, C6 and C7) were enriched in IFN pathways in Tg8 female cells (FDR< 0.05, logFC > 1, Fig 2C, marked with *). These cell clusters represent tissue resident MФ (C1: Ccr2-, MerTK+); inflammatory monocytes (C3 & C6: Ccr2+, Chil3+); and inflammatory MФ (C7: Cd14+, Cd9+, Spp1+, Fig 2D). In addition, qPCR confirmed female specific increase of ISGs in MФ with concomitant increase in CD11b+ cell abundance by flow cytometry on D2 (Fig 3A). This Tg8 female specific gene signature translates into histologic differences at D28 (Fig 3B).

Conclusion: This is the first demostration of sexually dimporhic myeloid gene signatures in human RA. We also validate the ZIA mouse model by mapping to human RA and demostrate that it is sexually dimorphic. We are currently exploring mechanistics studies to determine the roles of sex dependent factors, like steroid hormone signaling and X-inactivation, and their specific interactions with the IFN signaling axis.

Supporting image 1

Figure 1. Human RA Female macrophages subsets are enriched with inflammatory and IFN gene signature. We performed DEG and GSEA analysis between male and female subjects within each putative pathogenic MФ cluster. In 3 clusters (SPP1+, CXCL10+/STAT1+, and MERTK+ clusters), female cells were enriched with IFN related pathways (IFN-γ Response, EMT, Allograft Rejection) and other inflammatory pathways (TNF signaling, Inflammatory Response, A-C). To validate our mouse model, we built a mouse-to-human transfer learning model (a five-fold cross validated gradient boosted decision tree) to classify the human cell types (MERTK+; SPP1+, C1QA; STAT1+/CXCL10; IL1β/PLCG2). The model produced high quality predictions with an overall F1 score of 0.76 ± 0.1. This model was then transferred to the mouse dataset via mouse-to-human gene mapping and used to predict which human cluster each mouse cell is in. This analysis reveals that mouse ZIA synovium map to relevant sexually dimorphic human cell clusters (D).

Supporting image 2

Figure 2. scRNAseq reveals Tg8 Female specific monocyte/macrophage sub-clusters that are enriched with IFN genes. scRNAseq of synovial CD45+ cells depleted of neutrophils on day 7 of ZIA show distinct clusters of immune cells, and sub clusters of monocyte/macrophages in UMAP space (A&B). Differential gene expression comparing male WT to female WT and male Tg8 to female Tg8 with subsequent gene set enrichment shows clusters 1, 3, 6 & 7 (Asterisks) are enriched in IFN related genes (Dotted Box) in female Tg8 cells (D). Mean expression of marker genes per cluster demonstrate that cluster 1 and 2 are proliferating tissue resident macrophages (Ccr2-, Cd14-, Mrc1+, MerTK+), Cluster 3, 5, and 6 are inflammatory monocytes (CD14+, Ccr2+ Chil3+, Plac8+, and Ly6c2+) with cluster 6 being MHCII+, cluster 4 are other tissue resident M2-like macrophages (Mrc+, Trem2+, Adgre1+) and cluster 7 is a monocyte derived inflammatory macrophages (CD14+, CD9+, Spp1+). Analysis: R, Orchestrating Single Cell Experiments, deSeq2, EnrichR, Two-way ANOVA with Tukey’s post-hoc tests. scRNAseq: 4 mice pooled per group; Mo/cDC: Monocyte Derived or Conventional Dendritic Cells; Mo/Macs: Monocyte or Macrophages; NK: Natural Killer.

Supporting image 3

Figure 3. Early increase in IFIT1 in female macrophages with a concomitant increase macrophage abundance in female synovium that leads to increased synovitis at Day 28. On Day 2 after ZIA, FACS sorted F4-80+, CD11b+ macrophages show an increase of ISG expression, one example shown here IFIT1, in female cells. Macrophage numbers are also increased in female mice (A). Histologic analysis at Day 28 indicates that Female Tg8 mice develop increased synovial area and cell counts (B). H&E representative images are presented in the right panel with the synovium outlined in Yellow, note the large synovial reaction still present in the Tg8 female only (Arrow).


Disclosures: R. Bell: None; E. Cann: None; C. Yang: None; A. Rheumatoid Arthritis: None; A. Lakhanpal: None; L. Donlin: Bristol-Myers Squibb(BMS), 2, Stryker, 2; L. Ivashkiv: None.

To cite this abstract in AMA style:

Bell R, Cann E, Yang C, Rheumatoid Arthritis A, Lakhanpal A, Donlin L, Ivashkiv L. Synovial Macrophage Subsets Defined by ScRNAseq Demonstrate Sexually Dimorphic Gene Expression in RA and a Mouse Inflammatory Arthritis Model [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/synovial-macrophage-subsets-defined-by-scrnaseq-demonstrate-sexually-dimorphic-gene-expression-in-ra-and-a-mouse-inflammatory-arthritis-model/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/synovial-macrophage-subsets-defined-by-scrnaseq-demonstrate-sexually-dimorphic-gene-expression-in-ra-and-a-mouse-inflammatory-arthritis-model/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology